With Illumina 5-base chemistry, it’s now possible to detect genomic and epigenomic insights in a single assay. Fiona Kaper, VP, Head of Assay R&D, shares how this solution overcomes current challenges in multiomics: https://t.co/pjP4x7ziy4
What to expect from our Gold Sponsor Workshop at AGBT: Dr. Stephen Kingsmore, renowned genomics pioneer and CEO of Rady Children’s Institute for Genomic Medicine will take the stage to present early access data on our constellation mapped reads technology, a game-changer for the future of the whole-genome sequencing workflow and capabilities for deeper insights. Kingsmore studied its impact in the NICU setting for rapid diagnosis of rare disease. (1/2)
👩🔬👨🔬That’s us! Part of our Sequencing Unit and Bioinformatics Team, celebrating the arrival of the NovaSeq X Plus from @illumina!
🧬With the integration of the latest genomics technologies, we’ve elevated our sequencing capacity to the next level!
#CNAG#Genomics#HealthCare
If you are in Zurich and want to learn how to analyze proteomes using NGS join us on Nov14, 3pm. Really cool that Andrew Slatter, R&D, @illumina will join us and tell us all about their Protein Prep solution. Zoom link available but no apero for you https://t.co/jtl7TuJTH1
Researchers created a #GeneTherapy that reversed damage to the heart inflicted by a heart attack by enabling heart cells to spread and renew, according to a 2022 @ScienceTM study in pigs.
Learn more on #WorldHeartDay: https://t.co/JMjPKmRXlp
I have been using @illumina NGS instruments since 2010 and for a while now it feels like we are in a boring long term relationship. I have to say that today it feels like we did therapy and brought some excitement back into our relationship 😂 #EuropeanCoreSummit